699
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Astragalus glycyphyllos L.: antiviral activity and tablet dosage formulation of a standardized dry extract

, , , , , , , & show all
Article: 2221752 | Received 27 Mar 2023, Accepted 31 May 2023, Published online: 09 Jun 2023

References

  • Asyov B, Petrova A, Dimitrov D, et al. Conspectus of the Bulgarian vascular flora. Distribution maps and floristic elements. Bulgarian biodiversity foundation. Sofia (Bulgaria): Bulgarian Biodiversity Foundation; 2012.
  • Lysiuk R, Darmohray R. Pharmacology and ethnomedicine of the genus Astragalus. IJPPE. 2016;3:1–11. doi: 10.18052/www.scipress.com/IJPPE.3.46.
  • Krasteva I, Shkondrov A, Ionkova I, et al. Advances in phytochemistry, pharmacology and biotechnology of Bulgarian Astragalus species. Phytochem Rev. 2016;15(4):567–590. doi: 10.1007/s11101-016-9462-4.
  • Bratkov V, Shkondrov A, Zdraveva P, et al. Flavonoids from the genus Astragalus: phytochemistry and biological activity. Pharmacogn Rev. 2016;10(19):11–32. Available from: http://www.phcogrev.com/text.asp?2016/10/19/11/176550 doi: 10.4103/0973-7847.176550.
  • Shkondrov A, Krasteva I, Bucar F, et al. A new tetracyclic saponin from Astragalus glycyphyllos L. and its neuroprotective and hMAO-B inhibiting activity. Nat Prod Res. 2020;34(4):511–517. Available from: doi: 10.1080/14786419.2018.1491040.
  • Ionkova I, Shkondrov A, Zarev Y, et al. Anticancer secondary metabolites: from ethnopharmacology and identification in native complexes to biotechnological studies in species of genus Astragalus L. and Gloriosa L. Curr Issues Mol Biol. 2022;44(9):3884–3904. Available from: https://www.mdpi.com/1467-3045/44/9/267 doi: 10.3390/cimb44090267.
  • Shkondrov A, Simeonova R, Kondeva-Burdina M, et al. Study to evaluate the antioxidant activity of Astragalus glycyphyllos extract in carbon tetrachloride-induced oxidative stress in rats. EJMP. 2015;7(2):59–66. Available from: http://www.sciencedomain.org/abstract.php?iid=1018&id=13&aid=8249 doi: 10.9734/EJMP/2015/16259.
  • Georgieva A, Popov G, Shkondrov A, et al. Antiproliferative and antitumour activity of saponins from Astragalus glycyphyllos on myeloid Graffi tumour. J Ethnopharmacol. 2021;267:113519. doi: 10.1016/j.jep.2020.113519.
  • Salehi B, Carneiro JNP, Rocha JE, et al. Astragalus species: insights on its chemical composition toward pharmacological applications. Phyther Res. 2021;35(5):2445–2476. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ptr.6974 doi: 10.1002/ptr.6974.
  • Pistelli LF. Secondary metabolites of genus Astragalus: structure and biological activity. In: Atta-ur-Rahman, editor. Studies in natural products chemistry. Karachi: Elsevier Science BV; 2002. p. 443–545.
  • Verotta L, El-Sebakhy NA. Cycloartane and oleanane saponins from Astragalus sp. In: Atta-ur-Rahman, editor. Studies in natural products chemistry. Bioactive natural products (Part F) (Volume 25). Karachi: Elsevier Science BV; 2001. p. 179–234. Available from: https://www.sciencedirect.com/science/article/pii/S1572599501800089
  • Zhang P, Liu X, Liu H, et al. Astragalus polysaccharides inhibit avian infectious bronchitis virus infection by regulating viral replication. Microb Pathog. 2018;114:124–128. Available from: https://www.sciencedirect.com/science/article/pii/S0882401017313979 doi: 10.1016/j.micpath.2017.11.026.
  • Shkondrov A, Krasteva I. High resolution LC-MS/MS screening for secondary metabolites in Bulgarian species of genus Astragalus L. Quim Nova [Internet]. 2021;44(6):683–688. Available from: http://quimicanova.sbq.org.br/audiencia_pdf.asp?aid2=9283&nomeArquivo=AR2020-0353.pdf
  • Shkondrov A, Krasteva I, Ionkova I, et al. Production of saponins from in vitro cultures of Astragalus glycyphyllos and their antineoplastic activity. Biotechnol Biotechnol Equip [Internet]. 2019;33(1):1413–1418. Available from: doi: 10.1080/13102818.2019.1671222.
  • Shkondrov A, Krasteva I. Liquid chromatography – high resolution mass spectrometry screening of Astragalus hamosus and Astragalus corniculatus. PHAR. 2021;68(1):135–139. Available from: doi: 10.3897/pharmacia.68.e60621.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1–2):55–63. doi: 10.1016/0022-1759(83)90303-4.
  • Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Epidemiol. 1938;27(3):493–497. doi: 10.1093/oxfordjournals.aje.a118408.
  • Dulbecco R. Production of plaques in monolayer tissue cultures by single particles of an animal virus. Proc Natl Acad Sci U S A. 1952;38(8):747–752. doi: 10.1073/pnas.38.8.747.
  • Takeuchi H, Baba M, Shigeta S. An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds. J Virol Methods. 1991;33(1-2):61–71. Available from: https://www.sciencedirect.com/science/article/pii/016609349190008N doi: 10.1016/0166-0934(91)90008-n.
  • Hinkov A, Angelova P, Marchev A, et al. Nepeta nuda ssp. nuda L. water extract: inhibition of replication of some strains of human alpha herpes virus (genus simplex virus) in vitro, mode of action and NMR-based metabolomics. J Herb Med. 2020;21:100334. Available from: https://www.sciencedirect.com/science/article/pii/S2210803320300063 doi: 10.1016/j.hermed.2020.100334.
  • Prichard MN, Shipman C. A three-dimensional model to analyze drug-drug interactions. Antiviral Res. 1990;14(4–5):181–205. Available from: https://www.sciencedirect.com/science/article/pii/016635429090001N doi: 10.1016/0166-3542(90)90001-n.
  • Prichard MN, Aseltine KR, Shipman CJr. MacSynergyTM II. Ann Arbor (MI): University of Michigan; 1992.
  • Prichard MN, Aseltine KR, Shipman CJr. User’s manual. Ann Arbor (MI): University of Michigan; 1993.
  • Lopez-Santamarina A, Lamas A, del Carmen Mondragón A, et al. Probiotic effects against virus infections: new weapons for an old war. Foods [Internet]. 2021;10(1):130. Available from: https://www.mdpi.com/2304-8158/10/1/130 doi: 10.3390/foods10010130.
  • Liang Y, Zhang Q, Zhang L, et al. Astragalus membranaceus treatment protects Raw264.7 cells from influenza virus by regulating G1 phase and the TLR3-Mediated signaling pathway. Evid Based Complement Alternat Med. 2019;2019:2971604. doi: 10.1155/2019/2971604.
  • Khan HM, Raza SM, Anjum AA, et al. Antiviral, embryo toxic and cytotoxic activities of Astragalus membranaceus root extracts. Pak J Pharm Sci. 2019;32(1):137–142.
  • Yang K, Xie Q, Tang T, et al. Astragaloside IV as a novel CXCR4 antagonist alleviates osteoarthritis in the knee of monosodium iodoacetate-induced rats. Phytomedicine. 2023;108:154506. doi: 10.1016/j.phymed.2022.154506.
  • Saadullah M, Farid A, Ali A, et al. Molecular modeling study of novel lancifolamide bioactive molecule as an inhibitor of acetylcholinesterase (AChE), herpes simplex virus (HSV-1), and anti-proliferative proteins. Molecules. 2022;27(17):5480. doi: 10.3390/molecules27175480.
  • Mansour RB, Chaouachi F, Falleh H, et al. Powerful anti-inflammatory, anti-Herpes and anticancer capacities of Thymelaea microphylla L. and TLC phenolic identification. J Nat Prod Res Appl. 2022;1(3):1–16. doi: 10.46325/jnpra.v1i03.24.
  • Hadun AH, Mbaria J, Aboge GO. Phytochemical composition of Dichrocephala integrifolia crude extracts, antiviral activity and toxicity. Asian J Trop Biotechnol. 2022;19(2):72–81. doi: 10.13057/biotek/c190204.